Telesis Bio Valuation

Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Telesis Bio current Real Value cannot be determined due to lack of data. The regular price of Telesis Bio is $0.0. Our model measures the value of Telesis Bio from inspecting the company fundamentals such as Operating Margin of (6.76) %, return on equity of -1.48, and Shares Outstanding of 1.77 M as well as reviewing its technical indicators and probability of bankruptcy.

Telesis Bio Total Value Analysis

Telesis Bio is at this time forecasted to have valuation of 61.1 M with market capitalization of 5.73 M, debt of 34.38 M, and cash on hands of 654.75 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Telesis Bio fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
61.1 M
5.73 M
34.38 M
654.75 M

Telesis Bio Investor Information

About 38.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.11. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Telesis Bio recorded a loss per share of 30.42. The entity had not issued any dividends in recent years. The firm had 1:18 split on the 9th of May 2024. Based on the analysis of Telesis Bio's profitability, liquidity, and operating efficiency, Telesis Bio is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Telesis Bio Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Telesis Bio has an asset utilization ratio of 39.07 percent. This suggests that the Company is making $0.39 for each dollar of assets. An increasing asset utilization means that Telesis Bio is more efficient with each dollar of assets it utilizes for everyday operations.

Telesis Bio Ownership Allocation

Telesis Bio maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.

Telesis Bio Profitability Analysis

The company reported the previous year's revenue of 27.51 M. Net Loss for the year was (47.72 M) with profit before overhead, payroll, taxes, and interest of 15.6 M.

Telesis Bio Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding29.8 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in Telesis Pink Sheet

If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance